Atlas Trials

GA-68 DOTA-TOC of Somatostatin Positive Malignancies

Clinical trial NCT02177773 · TERMINATED

Trial details

NCT number
NCT02177773
Sponsor
University of California, San Francisco
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroendocrine TumorParagangliomaCarcinoid TumorsNeuroblastoma
Start date
2014-06-23
Primary completion
2017-08-07
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.